Search Results - Nai‐Kong V. Cheung

Refine Results
  1. 1
    Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma

    Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma by Nai‐Kong V. Cheung

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy

    Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy by Mahiuddin Ahmed, Nai‐Kong V. Cheung

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    GD2-Targeted Immunotherapy and Radioimmunotherapy

    GD2-Targeted Immunotherapy and Radioimmunotherapy by Konstantin Dobrenkov, Nai‐Kong V. Cheung

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics

    T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics by Zhanhong Wu, Nai‐Kong V. Cheung

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.

    Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cyto... by David H. Munn, Nai‐Kong V. Cheung

    Published 1989
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Neuroblastoma: developmental biology, cancer genomics and immunotherapy

    Neuroblastoma: developmental biology, cancer genomics and immunotherapy by Nai‐Kong V. Cheung, Michael A. Dyer

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies

    Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies by Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies

    Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies by Jeong A Park, Nai‐Kong V. Cheung

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies

    Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies by Dana L. Casey, Nai‐Kong V. Cheung

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Targets and Antibody Formats for Immunotherapy of Neuroblastoma

    Targets and Antibody Formats for Immunotherapy of Neuroblastoma by Jeong A Park, Nai‐Kong V. Cheung

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma

    GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma by Jeong A Park, Nai‐Kong V. Cheung

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Acute myeloid leukemia targets for bispecific antibodies

    Acute myeloid leukemia targets for bispecific antibodies by Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Promise and Challenges of T Cell Immunotherapy for Osteosarcoma

    Promise and Challenges of T Cell Immunotherapy for Osteosarcoma by Jeong A Park, Nai‐Kong V. Cheung

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Immunotherapy of Childhood Sarcomas

    Immunotherapy of Childhood Sarcomas by Stephen S. Roberts, Alexander J. Chou, Nai‐Kong V. Cheung

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor

    Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stim... by Irene Y. Cheung, Katharine C. Hsu, Nai‐Kong V. Cheung

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy

    ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy by Guilly Rebagay, Su Yan, Cheng Liu, Nai‐Kong V. Cheung

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai-KongV. Cheung

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study

    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy

    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy by Nai‐Kong V. Cheung, Irina Ostrovnaya, Deborah Kuk, Irene Y. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: